BI 655066 versus placebo In a Multicenter randomized double-blind study in patients with Moderate to severe cHronic plAque psoriasis evaluatiNg the effiCacy and safety with randomized withdrawal and rE-treatment (IMMhance)

Clinical Trial Grant

Duke Scholars

Principal Investigator John Carroll Murray Dermatology

Administered By

Dermatology

Awarded By

Boehringer Ingelheim Pharmaceuticals, Inc.

Start Date

March 1, 2016

End Date

February 29, 2020

Administered By

Dermatology

Awarded By

Boehringer Ingelheim Pharmaceuticals, Inc.

Start Date

March 1, 2016

End Date

February 29, 2020